The European Commission’s New Compulsory Licensing Proposal: A Step Forward?
Bill of Health
MAY 5, 2023
By Sarah Gabriele On April 27, 2023, the European Commission proposed new legislation that would allow companies to make drugs without the patent holder’s consent in emergency situations. The COVID-19 crisis demonstrated how the need for protecting and incentivizing innovation clashed with the need to make products widely available.
Let's personalize your content